Cita APA

Egeberg, A., Merola, J. F., Schäkel, K., Puig Sanz, L., Mahar, P. D., Wang, I. Y., . . . Griffiths, C. E. (2023). Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes.

Citación estilo Chicago

Egeberg, Alexander|||0000-0001-8257-1816, Joseph F.|||0000-0001-6514-4353 Merola, Knut Schäkel, Lluís|||0000-0001-6083-0952 Puig Sanz, Patrick D. Mahar, Isabella Yali Wang, Imre Pavo, Christopher Schuster, y Christopher E.M.|||0000-0001-5371-4427 Griffiths. Efficacy of Ixekizumab in Patients With Moderate-to-severe Plaque Psoriasis and Prediabetes or Type 2 Diabetes. 2023.

Cita MLA

Egeberg, Alexander|||0000-0001-8257-1816, et al. Efficacy of Ixekizumab in Patients With Moderate-to-severe Plaque Psoriasis and Prediabetes or Type 2 Diabetes. 2023.